Progress and challenges in colorectal cancer screening and surveillance
- PMID: 20167216
- DOI: 10.1053/j.gastro.2010.02.006
Progress and challenges in colorectal cancer screening and surveillance
Abstract
Colorectal cancer is a leading cause of cancer death throughout the world. There is evidence that screening of average-risk individuals can result in mortality reduction with early cancer detection and cancer prevention by detection and removal of cancer precursor lesions. The optimal form of screening is not clear. Fecal screening tests can be performed at home at low initial cost, but current versions lack high sensitivity for cancer precursor lesions, and tests need to be repeated at regular intervals. Adherence to repeat testing for negative tests and referral for colonoscopy for positive tests are important elements of program effectiveness. Structural examinations of the colon are more invasive and may result in detection of both early cancer and cancer precursor lesions. Every screening program has advantages and limitations, but each program ultimately depends on quality and patient adherence.
Similar articles
-
Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S198-204. doi: 10.1111/j.1440-1746.2008.05556.x. J Gastroenterol Hepatol. 2008. PMID: 19120898
-
Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese: a cost-effectiveness analysis.Asian Pac J Cancer Prev. 2012;13(5):1761-6. doi: 10.7314/apjcp.2012.13.5.1761. Asian Pac J Cancer Prev. 2012. PMID: 22901118
-
Colon cancer screening and surveillance controversies.Curr Opin Gastroenterol. 2009 Sep;25(5):422-7. doi: 10.1097/MOG.0b013e32832d1e2a. Curr Opin Gastroenterol. 2009. PMID: 19465849 Review.
-
Guidelines for colorectal cancer screening--a puzzle of tests and strategies.Acta Clin Belg. 2010 Nov-Dec;65(6):433-6. doi: 10.1179/acb.2010.65.6.012. Acta Clin Belg. 2010. PMID: 21268961 Review.
-
Screening and surveillance for colorectal carcinoma.Hematol Oncol Clin North Am. 1997 Aug;11(4):579-608. doi: 10.1016/s0889-8588(05)70452-4. Hematol Oncol Clin North Am. 1997. PMID: 9257147 Review.
Cited by
-
CircHADHA-augmented autophagy suppresses tumor growth of colon cancer by regulating autophagy-related gene via miR-361.Front Oncol. 2022 Oct 13;12:937209. doi: 10.3389/fonc.2022.937209. eCollection 2022. Front Oncol. 2022. PMID: 36313671 Free PMC article.
-
A randomized double-blind placebo-controlled trial to evaluate the value of a single bolus intravenous alfentanil in CT colonography.BMC Gastroenterol. 2011 Nov 23;11:128. doi: 10.1186/1471-230X-11-128. BMC Gastroenterol. 2011. PMID: 22111658 Free PMC article. Clinical Trial.
-
Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance.Gastroenterology. 2013 Oct;145(4):775-81.e2. doi: 10.1053/j.gastro.2013.06.037. Epub 2013 Jun 22. Gastroenterology. 2013. PMID: 23796457 Free PMC article.
-
Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results.BMC Cancer. 2019 Jan 10;19(1):47. doi: 10.1186/s12885-018-5191-y. BMC Cancer. 2019. PMID: 30630450 Free PMC article.
-
Influences and Practices in Colorectal Cancer Screening Among Health Care Providers Serving Northern Plains American Indians, 2011-2012.Prev Chronic Dis. 2016 Dec 15;13:E167. doi: 10.5888/pcd13.160267. Prev Chronic Dis. 2016. PMID: 27978410 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical